HealthcareServices

Global Interventional Oncology Market Analysis 2025–2029: Opportunities for Strategic Growth

November 20, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Interventional Oncology Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The interventional oncology market size has shown strong growth in recent times. It is anticipated to increase from $2.49 billion in 2024 to $2.72 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.2%. The expansion during prior periods can be attributed to the rising global occurrence of cancer, the heightened adoption of procedures that are minimally invasive, increasing healthcare investments in emerging economies, a growing demand for image-guided therapies, and greater public awareness of the benefits of interventional oncology.

The interventional oncology market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $3.82 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.8%. Factors contributing to this growth during the forecast period include an increased demand for outpatient oncology procedures, the expanding application of combination therapies alongside immuno-oncology, a rise in clinical trials focused on image-guided therapies, broader access to interventional oncology within emerging markets, and the increasing significance of precision medicine in developing treatment plans. Key trends anticipated over the forecast period encompass advancements in image-guided ablation technologies, the creation of artificial intelligence-powered diagnostic tools, breakthroughs in targeted drug-delivery systems, enhancements in minimally invasive treatment devices, and the evolution of personalized oncology treatment solutions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27318&type=smp

What Are The Drivers Pushing New Developments In The Interventional Oncology Market?

The increasing prevalence of cancer is projected to stimulate the growth of the interventional oncology market moving forward. The term “prevalence of cancer” denotes the total count of individuals, both newly and previously diagnosed, who are currently alive with a history of the disease at a specific juncture. This increase in cancer prevalence is attributed to lifestyle-related risk factors such as poor dietary choices, smoking, alcohol consumption, and exposure to environmental pollutants, all of which elevate the likelihood of developing various cancers. Interventional oncology assists in treating cancer by offering minimally invasive, precise therapies that target tumors directly. It improves patient outcomes by minimizing damage to healthy tissues and ensuring faster recovery periods compared to traditional treatments. For instance, in July 2024, data from the Australian Institute of Health and Welfare, an Australia-based government agency, indicated that cancer cases diagnosed in Australia totaled 160,570 in 2022, representing an increase of 3,789 cases from 156,781 in 2021. Thus, the growing prevalence of cancer is a key driver for the expansion of the interventional oncology market.

How Is The Interventional Oncology Market Classified Into Different Segments?

The interventional oncology market covered in this report is segmented

1) By Type: Radiation Therapy Devices, Ablation Devices, Embolization Devices

2) By Technology Type: Ultrasound, Computed Tomography Guided, Magnetic Resonance-Guided

3) By Procedure: Tumor Ablation, Tumor Biopsy, Vascular Interventions, Palliative Care

4) By Application Areas: Liver Cancer, Lung Cancer, Kidney Cancer, Pancreatic Cancer, Prostate Cancer

5) By End-Users: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Research And Academic Institutions

Subsegments:

1) By Radiation Therapy Devices: Linear Accelerators, Proton Therapy Systems, Brachytherapy Devices

2) By Ablation Devices: Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Irreversible Electroporation Systems

3) By Embolization Devices: Microspheres, Coil Embolization Devices, Liquid Embolic Agents, Embolic Protection Devices

What Long-Term Trends Will Shape The Future Growth Of The Interventional Oncology Industry?

Leading companies in the interventional oncology market are prioritizing the development of sophisticated products, such as microcatheter-based embolization systems. These innovations aim to deliver precise, targeted cancer therapy while effectively minimizing damage to surrounding healthy tissue. Microcatheter-based embolization systems themselves refer to medical devices that employ tiny, flexible catheters to accurately deliver embolic agents into blood vessels, aiming to block or reduce blood flow, typically utilized for treating tumors, vascular malformations, or internal bleeding. For instance, in March 2025, Terumo Corporation, a Japan-based medical device company, unveiled the Occlusafe balloon occlusion catheter. This product is based on their advanced Balloon-TACE (B-TACE) therapy, specifically developed for the management of liver cancer, particularly hepatocellular carcinoma (HCC). This specialized microcatheter skillfully uses the pressure gradient effect to redirect blood flow and gain access to the microcirculation, which allows for higher concentrations of therapeutic agents directly at the tumor site while significantly minimizing off-target embolization. This focused approach seeks to improve clinical outcomes in challenging liver cancer cases by enhancing the precision of drug delivery and offering superior visualization during procedures.

Who Are The Top Performing Companies In The Interventional Oncology Market In Recent Years?

Major companies operating in the interventional oncology market are Johnson & Johnson, Siemens Healthineers AG, Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Terumo Corporation, Hologic Inc., Teleflex Incorporated, Lantheus Holdings Inc., Penumbra Inc., Merit Medical Systems Inc., Guerbet S.A, Asahi Intecc Co. Ltd., AngioDynamics Inc., Sirtex Medical Limited., Delcath Systems Inc., ABK Biomedical Inc., Profound Medical Inc., IceCure Medical Ltd., Minimax Medical Holding Group.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/interventional-oncology-global-market-report

Which Region Currently Holds The Largest Share Of The Interventional Oncology Market?

North America was the largest region in the interventional oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Interventional Oncology Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27318&type=smp

Browse Through More Reports Similar to the Global Interventional Oncology Market 2025, By The Business Research Company

Motor Insurance Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/motor-insurance-global-market-report

Golf Cart And Neighborhood Electric Vehicle Nev Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/golf-cart-and-neighborhood-electric-vehicle-nev-global-market-report

Renewable Energy Insurance Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/renewable-energy-insurance-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795